Amneal Pharmaceuticals, Inc.
AMRX
|
$5.46
0.18%
0.18%
1.2M
|
Health Technology
(0.0% 1d) (-7.8% 1m) (232.3% 1y) (0.0% 2d) (-1.6% 3d) (-4.2% 7d) (7.69% volume)
Earnings Calendar:
Market Cap: $ 1,684,706,085
http://www.amneal.com
Sec Filling | Patents | 5500 employees
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
injection dividends
Drugs
Zolmitriptan (Zolmitriptan)ZOMIG (Zolmitriptan)
ZOMIG ZMT (Zolmitriptan)
add to watch list Paper trade email alert is off
Press-releases
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: -1.08%
H: 1.09%
C: -0.55%
rtu first
Amneal to Report First Quarter 2024 Results on May 3, 2024
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: -0.52%
H: 3.86%
C: 0.0%
first report results
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: -2.64%
fda approval
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: -1.89%
H: 1.75%
C: 0.0%
ipx203 biotech agreement
Amneal to Participate at Upcoming Investor Conference
Published: 2024-02-13 (Crawled : 13:30) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: -3.84%
H: 2.57%
C: -0.45%
conference
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 0.18%
H: 1.83%
C: 1.83%
ipx203 drug resubmission application response
I-Mab Signs Agreement to Divest its Assets and Business Operations in China
Published: 2024-02-07 (Crawled : 11:00) - prnewswire.com
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.29%
IMAB | $1.81 1.12% 1.1% 390K
|
Health Technology
|
| O: 2.49%
H: 0.97%
C: -2.91%
business agreement china
Deb Autor, Former FDA Deputy Commissioner, Appointed CEO of Healthcare Innovation Catalysts
Published: 2024-02-01 (Crawled : 13:00) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 2.8%
H: 0.55%
C: 0.18%
fda ceo innovation
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
Published: 2024-01-25 (Crawled : 12:30) - globenewswire.com
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 1.57%
H: 0.73%
C: -0.82%
ipx203 license pharmaceuticals therapeutics agreement
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Published: 2024-01-10 (Crawled : 14:30) - biospace.com/
AMRX | $5.46 0.18% 0.18% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.7%
C: -3.16%
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10